Literature DB >> 27487899

Integrated PET/MR breast cancer imaging: Attenuation correction and implementation of a 16-channel RF coil.

Mark Oehmigen1, Maike E Lindemann1, Titus Lanz2, Sonja Kinner3, Harald H Quick4.   

Abstract

PURPOSE: This study aims to develop, implement, and evaluate a 16-channel radiofrequency (RF) coil for integrated positron emission tomography/magnetic resonance (PET/MR) imaging of breast cancer. The RF coil is designed for optimized MR imaging performance and PET transparency and attenuation correction (AC) is applied for accurate PET quantification.
METHODS: A 16-channel breast array RF coil was designed for integrated PET/MR hybrid imaging of breast cancer lesions. The RF coil features a lightweight rigid design and is positioned with a spacer at a defined position on the patient table of an integrated PET/MR system. Attenuation correction is performed by generating and applying a dedicated 3D CT-based template attenuation map. Reposition accuracy of the RF coil on the system patient table while using the positioning frame was tested in repeated measurements using MR-visible markers. The MR, PET, and PET/MR imaging performances were systematically evaluated using modular breast phantoms. Attenuation correction of the RF coil was evaluated with difference measurements of the active breast phantoms filled with radiotracer in the PET detector with and without the RF coil in place, serving as a standard of reference measurement. The overall PET/MR imaging performance and PET quantification accuracy of the new 16-channel RF coil and its AC were then evaluated in first clinical examinations on ten patients with local breast cancer.
RESULTS: The RF breast array coil provides excellent signal-to-noise ratio and signal homogeneity across the volume of the breast phantoms in MR imaging and visualizes small structures in the phantoms down to 0.4 mm in plane. Difference measurements with PET revealed a global loss and thus attenuation of counts by 13% (mean value across the whole phantom volume) when the RF coil is placed in the PET detector. Local attenuation ranging from 0% in the middle of the phantoms up to 24% was detected in the peripheral regions of the phantoms at positions closer to attenuating hardware structures of the RF coil. The position accuracy of the RF coil on the patient table when using the positioning frame was determined well below 1 mm for all three spatial dimensions. This ensures perfect position match between the RF coil and its three-dimensional attenuation template during the PET data reconstruction process. When applying the CT-based AC of the RF coil, the global attenuation bias was mostly compensated to ±0.5% across the entire breast imaging volume. The patient study revealed high quality MR, PET, and combined PET/MR imaging of breast cancer. Quantitative activity measurements in all 11 breast cancer lesions of the ten patients resulted in increased mean difference values of SUVmax 11.8% (minimum 3.2%; maximum 23.2%) between nonAC images and images when AC of the RF breast coil was applied. This supports the quantitative results of the phantom study as well as successful attenuation correction of the RF coil.
CONCLUSIONS: A 16-channel breast RF coil was designed for optimized MR imaging performance and PET transparency and was successfully integrated with its dedicated attenuation correction template into a whole-body PET/MR system. Systematic PET/MR imaging evaluation with phantoms and an initial study on patients with breast cancer provided excellent MR and PET image quality and accurate PET quantification.

Entities:  

Mesh:

Year:  2016        PMID: 27487899     DOI: 10.1118/1.4959546

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  6 in total

1.  Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI.

Authors:  Julian Kirchner; Johannes Grueneisen; Ole Martin; Mark Oehmigen; Harald H Quick; Ann-Kathrin Bittner; Oliver Hoffmann; Marc Ingenwerth; Onofrio Antonio Catalano; Philipp Heusch; Christian Buchbender; Michael Forsting; Gerald Antoch; Ken Herrmann; Lale Umutlu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-28       Impact factor: 9.236

2.  Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR.

Authors:  Mark Oehmigen; Maike E Lindemann; Marcel Gratz; Julian Kirchner; Verena Ruhlmann; Lale Umutlu; Jan Ole Blumhagen; Matthias Fenchel; Harald H Quick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-09       Impact factor: 9.236

3.  MLAA-based attenuation correction of flexible hardware components in hybrid PET/MR imaging.

Authors:  Thorsten Heußer; Christopher M Rank; Yannick Berker; Martin T Freitag; Marc Kachelrieß
Journal:  EJNMMI Phys       Date:  2017-03-01

4.  Fabrication and evaluation of bilateral Helmholtz radiofrequency coil for thermo-stable breast image with reduced artifacts.

Authors:  Young Han Lee; Kyu-Ho Song; Jaemoon Yang; Won Jun Kang; Keum Sil Lee; Min Jung Kim; Eun-Kyung Kim; Dan Heo; Bo-Young Choe; Jin-Suck Suh
Journal:  J Appl Clin Med Phys       Date:  2021-12-01       Impact factor: 2.102

5.  Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Authors:  Lale Umutlu; Julian Kirchner; Nils-Martin Bruckmann; Janna Morawitz; Gerald Antoch; Saskia Ting; Ann-Kathrin Bittner; Oliver Hoffmann; Lena Häberle; Eugen Ruckhäberle; Onofrio Antonio Catalano; Michal Chodyla; Johannes Grueneisen; Harald H Quick; Wolfgang P Fendler; Christoph Rischpler; Ken Herrmann; Peter Gibbs; Katja Pinker
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.575

6.  Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding.

Authors:  Lale Umutlu; Julian Kirchner; Nils Martin Bruckmann; Janna Morawitz; Gerald Antoch; Marc Ingenwerth; Ann-Kathrin Bittner; Oliver Hoffmann; Johannes Haubold; Johannes Grueneisen; Harald H Quick; Christoph Rischpler; Ken Herrmann; Peter Gibbs; Katja Pinker-Domenig
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.